Cost-effectiveness of citicoline versus conventional treatment in acute ischemic stroke

References

• Evers SMAA, Struijs JN, Ament AJHA, van Genugten MLL, Jager JC, van den Bos GAM. International comparison of stroke cost studies. Stroke35, 1209–1215 (2004).
   PubMed Web of Science ®Google Scholar
• Ovbiagele B, Kidwell CS, Starkman S, Saver JL. Potential role of neuroprotective agents in the treatment of patients with acute ischemic stroke. Curr. Treat. Options Neurol.5, 367–375 (2003).
   PubMedGoogle Scholar
• Gradison M. Decreasing the morbidity, mortality, and cost of stroke through awareness and prevention. Am. Fam. Physician68, 2335, 2339–2340 (2003).
   PubMedGoogle Scholar
• Martí-Vilalta J, Arboix A. The Barcelona Stroke Registry. Eur. Neurol.41, 135–142 (1999).
   PubMed Web of Science ®Google Scholar
• Boix R, del Barrio JL, Saz P et al. Stroke prevalence among the Spanish elderly: an analysis based on screening surveys. BMC Neurol.6, 36 (2006).
   PubMedGoogle Scholar
• Truelsen T, Ekman M, Boysen G. Cost of stroke in Europe. Eur. J. Neurol.12(Suppl. 1), 78–84 (2005).
   PubMedGoogle Scholar
• Gerzeli S, Tarricone R, Zolo P, Colangelo I, Busca MR, Gandolfo C. The economic burden of stroke in Italy. The EcLIPSE Study: Economic Longitudinal Incidence-based Project for Stroke Evaluation. Neurol. Sci.26, 72–80 (2005).
   PubMed Web of Science ®Google Scholar
• Youman P, Wilson K, Harraf F, Kalra L. The economic burden of stroke in the United Kingdom. Eur. J. Neurol.21(Suppl. 1), 43–50 (2003).
   Google Scholar
• Hack W, Kaste M, Bogousslavsky J et al. European Stroke Initiative Recommendations for Stroke Management – Update 2003. Cerebrovasc. Dis.16, 311–337 (2003).
   PubMed Web of Science ®Google Scholar
• Adibhatla RM, Hatcher JF. Citicoline mechanisms and clinical efficacy in cerebral ischemia. J. Neuroscience Res.70, 133–139 (2002).
   PubMed Web of Science ®Google Scholar
• Saver JL, Wilterdink J. Choline precursors in acute and subacute human stroke: a meta-analysis. Stroke33, 353 (2002) (Abstract).
   Web of Science ®Google Scholar
• Dávalos A, Castillo J, Álvarez-Sabin J et al. Oral citicoline in acute ischemic stroke. An individual patient data pooling analysis of clinical trials. Stroke33, 2850–2857 (2002).
   PubMed Web of Science ®Google Scholar
• Warach SHK, Harnett K. Dose dependent reduction in infarct growth with citicoline treatment: evidence of neuroprotection in human stroke? Stroke33, 354 (2002) (Abstract).
   Google Scholar
• Brott T, Adams HP, Olinger CP et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke20, 864–870 (1995).
   Google Scholar
• de Haan R, Limburg M, Bossuyt P, van der Meulen J, Aaronson N. The clinical meaning of Rankin “handicap” grades after stroke. Stroke26, 2027–2030 (1989).
   Google Scholar
• Mahoney F, Barthel D. Functional evaluation: the Barthel Index. Md State Med. J.14, 56–61 (1965).
   Google Scholar
• Tilley BC, Marler J, Geller NL et al. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. Stroke27, 2136–2142 (1996).
   PubMed Web of Science ®Google Scholar
• Martínez Vila E, Irimia P, Urrestarazu E, Gallego J. El cost del ictus. An. Sist. Sanit. Navar.23(Suppl. 3), 33–38 (2000).
   Google Scholar
• León Colombo T, Segura-Martín T, Vivancos-Mora J. Hospitalización versus asistencia domiciliaria en el ictus. Rev. Neurol.25, 1126–1129 (1997).
   PubMedGoogle Scholar
• Carod-Artal FJ, Egido-Navarro JA, Gonzalez-Gutierrez JL, Varela de Seijas E. Direct cost of cerebrovascular disease during the first year of follow-up. [Article in Spanish]. Rev. Neurol.28, 1123–1130 (1999).
   PubMedGoogle Scholar
• Vallejo JA, Carreras M, Marimón Suñol S et al. Análisis de costes asistenciales en los centros comarcales de rehabilitación. Mapfre Medicina12, 81–96 (2001).
   Google Scholar
• Payne KA, Huybrechts KF, Caro JJ, Craig Green TJ, Klittich WS. Long term cost-of-illness in stroke: an international review. Eur. J. Neurol.20, 813–825 (2002).
   Google Scholar
• Dewey HM, Thrift AG, Mihalopoulos C et al. Lifetime cost of stroke subtypes in Australia: findings from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke34, 2502–2507 (2003).
   PubMed Web of Science ®Google Scholar
• Luengo-Fernandez R, Gray AM, Rothwell PM. Population-based study of determinants of initial secondary care costs of acute stroke in the United Kingdom. Stroke37, 2579–2587 (2006).
   PubMedGoogle Scholar
• Mamoli A, Censori B, Casto L, Sileo C, Cesana B, Camerlingo M. An analysis of the costs of ischemic stroke in an Italian stroke unit. Neurology53, 112–116 (1999).
   PubMed Web of Science ®Google Scholar
• Yoneda Y, Okuda S, Hamada R et al. Hospital cost of ischemic stroke and intracerebral hemorrhage in Japanese stroke centers. Health Policy73, 202–211 (2005).
   PubMed Web of Science ®Google Scholar
• Weimar C, Weber C, Wagner M et al. Management patterns and health care use after intracerebral hemorrhage. A cost-of-illness study from a societal perspective in Germany. Cerebrovasc. Dis.15, 29–36 (2003).
   PubMedGoogle Scholar
• Bergman L, van der Meulen JHP, Limburg M, Habbema JDF. Costs of medical care after first-ever stroke in the Netherlands. Stroke26, 1830–1836 (1995).
   PubMed Web of Science ®Google Scholar
• Terent A, Marke LA, Asplund K, Norrving B, Jonsson E, Wester PO. Costs of stroke in Sweden. A national perspective. Stroke25, 2363–2369 (1994).
   PubMed Web of Science ®Google Scholar
• Epifanov Y, Dodel R, Haacke C et al. Costs of acute stroke care on regular neurological wards: acomparison with stroke unit setting. Health Policy81(2–3), 339–349 (2007).
   PubMed Web of Science ®Google Scholar